Earlier Use of Exelixis/Ipsen's Cabozantinib Hits Hurdle In Liver Cancer

Top-line COSMIC-312 Results

 
• By John Davis
  
liver cancer
PFS But Not OS Improved In Liver Cancer • Source: Alamy

More from Clinical Trials

More from R&D